Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: Nektar Therapeutics, 3 years.
Nektar Therapeutics
Director
Viridian Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Nektar Therapeutics June 5, 202494.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 23, 2026 | Nektar Therapeutics | Grant or award | +2,000 | — | — |
| May 2, 2024 | BioMarin Pharmaceutical Inc. | Open-market sale | −5,000 | $82.91 | $414,550 |
| Apr 30, 2024 | BioMarin Pharmaceutical Inc. | Grant or award | +300 | $68.65 | $20,595 |
| Mar 15, 2024 | BioMarin Pharmaceutical Inc. | Shares withheld for tax | −22,580 | $83.87 | $1,893,785 |
| Mar 5, 2024 | BioMarin Pharmaceutical Inc. | Open-market sale | −4,000 | $87.07 | $348,280 |
| Feb 27, 2024 | BioMarin Pharmaceutical Inc. | Grant or award | +21,440 | — | — |
| Feb 27, 2024 | BioMarin Pharmaceutical Inc. | Grant or award | +9,338 | — | — |
| Feb 27, 2024 | BioMarin Pharmaceutical Inc. | Grant or award | +6,465 | — | — |
| Sep 18, 2023 | Nektar Therapeutics | Open-market sale | −4,359 | $0.69 | $3,008 |
| Aug 16, 2023 | BioMarin Pharmaceutical Inc. | Open-market sale | −5,000 | $90.00 | $450,000 |
| Apr 28, 2023 | BioMarin Pharmaceutical Inc. | Grant or award | +318 | $66.88 | $21,268 |
| Mar 16, 2023 | BioMarin Pharmaceutical Inc. | Shares withheld for tax | −20,510 | $93.41 | $1,915,839 |
| Mar 15, 2023 | BioMarin Pharmaceutical Inc. | Grant or award | +10,110 | — | — |
| Mar 15, 2023 | BioMarin Pharmaceutical Inc. | Shares withheld for tax | −3,971 | $87.74 | $348,416 |
| Feb 28, 2023 | BioMarin Pharmaceutical Inc. | Grant or award | +20,760 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.